Drug profile · INN
sofosbuvir + velpatasvir + voxilaprevir
VOSEVI
sofosbuvir + velpatasvir + voxilaprevir (VOSEVI) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — sofosbuvir + velpatasvir + voxilaprevir
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
sofosbuvir + velpatasvir + voxilaprevir (VOSEVI) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is sofosbuvir + velpatasvir + voxilaprevir?
sofosbuvir + velpatasvir + voxilaprevir (VOSEVI) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
What is the brand name for sofosbuvir + velpatasvir + voxilaprevir?
VOSEVI is a marketed brand name for sofosbuvir + velpatasvir + voxilaprevir. Check FDA Drugs@FDA for the current US label holder and prescribing information.